id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2004-E-0270-0007,FDA,FDA-2004-E-0270,Determination of Regulatory Review Period for Purposes of Patent Extension; SENSIPAR,Notice,N-Notice,2009-05-14T04:00:00Z,2009,5,2009-05-14T04:00:00Z,2009-07-14T03:59:59Z,2009-05-15T07:34:10Z,E9-11219,0,0,0900006480991e92
FDA-2004-E-0270-0006,FDA,FDA-2004-E-0270,FDA/CDER to US Patent and Trademark Office -  Letter,Other,LET-Letter,2009-04-28T04:00:00Z,2009,4,2009-04-28T04:00:00Z,,2009-04-28T18:34:06Z,,0,0,090000648096de01
FDA-2004-E-0270-0005,FDA,FDA-2004-E-0270,Duplicate - Application for Patent Term Extension from NPS Pharmaceuticals Inc.,Other,Application,2009-04-28T04:00:00Z,2009,4,2009-04-28T04:00:00Z,,2025-11-18T21:18:05Z,,0,0,0900006480472212